Literature DB >> 22573816

Control of bone resorption in mice by Schnurri-3.

Marc N Wein1, Dallas C Jones, Jae-Hyuck Shim, Antonios O Aliprantis, Rosalyn Sulyanto, Vanja Lazarevic, Sandra L Poliachik, Ted S Gross, Laurie H Glimcher.   

Abstract

Mice lacking the large zinc finger protein Schnurri-3 (Shn3) display increased bone mass, in part, attributable to augmented osteoblastic bone formation. Here, we show that in addition to regulating bone formation, Shn3 indirectly controls bone resorption by osteoclasts in vivo. Although Shn3 plays no cell-intrinsic role in osteoclasts, Shn3-deficient animals show decreased serum markers of bone turnover. Mesenchymal cells lacking Shn3 are defective in promoting osteoclastogenesis in response to selective stimuli, likely attributable to reduced expression of the key osteoclastogenic factor receptor activator of nuclear factor-κB ligand. The bone phenotype of Shn3-deficient mice becomes more pronounced with age, and mice lacking Shn3 are completely resistant to disuse osteopenia, a process that requires functional osteoclasts. Finally, selective deletion of Shn3 in the mesenchymal lineage recapitulates the high bone mass phenotype of global Shn3 KO mice, including reduced osteoclastic bone catabolism in vivo, indicating that Shn3 expression in mesenchymal cells directly controls osteoblastic bone formation and indirectly regulates osteoclastic bone resorption.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573816      PMCID: PMC3361406          DOI: 10.1073/pnas.1205848109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3.

Authors:  Dallas C Jones; Marc N Wein; Mohamed Oukka; Jochen G Hofstaetter; Melvin J Glimcher; Laurie H Glimcher
Journal:  Science       Date:  2006-05-26       Impact factor: 47.728

2.  A mammalian homolog of Drosophila schnurri, KRC, regulates TNF receptor-driven responses and interacts with TRAF2.

Authors:  Mohamed Oukka; Sean T Kim; Geancarlo Lugo; Jenny Sun; Lai-Chu Wu; Laurie H Glimcher
Journal:  Mol Cell       Date:  2002-01       Impact factor: 17.970

3.  A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss.

Authors:  Kazuhiro Aoki; Hiroaki Saito; Cecile Itzstein; Masaji Ishiguro; Tatsuya Shibata; Roland Blanque; Anower Hussain Mian; Mariko Takahashi; Yoshifumi Suzuki; Masako Yoshimatsu; Akira Yamaguchi; Pierre Deprez; Patrick Mollat; Ramachandran Murali; Keiichi Ohya; William C Horne; Roland Baron
Journal:  J Clin Invest       Date:  2006-05-04       Impact factor: 14.808

4.  Botox induced muscle paralysis rapidly degrades bone.

Authors:  Sarah E Warner; David A Sanford; Blair A Becker; Steven D Bain; Sundar Srinivasan; Ted S Gross
Journal:  Bone       Date:  2005-09-26       Impact factor: 4.398

5.  Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts.

Authors:  G P Thomas; S U Baker; J A Eisman; E M Gardiner
Journal:  J Endocrinol       Date:  2001-08       Impact factor: 4.286

Review 6.  Toward a molecular understanding of skeletal development.

Authors:  A Erlebacher; E H Filvaroff; S E Gitelman; R Derynck
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

7.  Transient muscle paralysis degrades bone via rapid osteoclastogenesis.

Authors:  Antonios O Aliprantis; Marina Stolina; Paul J Kostenuik; Sandra L Poliachik; Sarah E Warner; Steven D Bain; Ted S Gross
Journal:  FASEB J       Date:  2011-11-28       Impact factor: 5.191

8.  Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis.

Authors:  G Sabatakos; N A Sims; J Chen; K Aoki; M B Kelz; M Amling; Y Bouali; K Mukhopadhyay; K Ford; E J Nestler; R Baron
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

Review 9.  RANKL-RANK signaling in osteoclastogenesis and bone disease.

Authors:  Teiji Wada; Tomoki Nakashima; Nishina Hiroshi; Josef M Penninger
Journal:  Trends Mol Med       Date:  2005-12-13       Impact factor: 11.951

10.  Leptin regulation of bone resorption by the sympathetic nervous system and CART.

Authors:  Florent Elefteriou; Jong Deok Ahn; Shu Takeda; Michael Starbuck; Xiangli Yang; Xiuyun Liu; Hisataka Kondo; William G Richards; Tony W Bannon; Masaki Noda; Karine Clement; Christian Vaisse; Gerard Karsenty
Journal:  Nature       Date:  2005-02-20       Impact factor: 49.962

View more
  18 in total

1.  Human immunodeficiency virus type 1 enhancer-binding protein 3 is essential for the expression of asparagine-linked glycosylation 2 in the regulation of osteoblast and chondrocyte differentiation.

Authors:  Katsuyuki Imamura; Shingo Maeda; Ichiro Kawamura; Kanehiro Matsuyama; Naohiro Shinohara; Yuhei Yahiro; Satoshi Nagano; Takao Setoguchi; Masahiro Yokouchi; Yasuhiro Ishidou; Setsuro Komiya
Journal:  J Biol Chem       Date:  2014-02-21       Impact factor: 5.157

2.  Bromodomain and Extra-terminal (BET) Protein Inhibitors Suppress Chondrocyte Differentiation and Restrain Bone Growth.

Authors:  Ningning Niu; Rui Shao; Guang Yan; Weiguo Zou
Journal:  J Biol Chem       Date:  2016-11-07       Impact factor: 5.157

3.  Ubiquitin E3 ligase Wwp1 negatively regulates osteoblast function by inhibiting osteoblast differentiation and migration.

Authors:  Lei Shu; Hengwei Zhang; Brendan F Boyce; Lianping Xing
Journal:  J Bone Miner Res       Date:  2013-09       Impact factor: 6.741

4.  A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation.

Authors:  Qinggang Dai; Yujiao Han; Furong Xie; Xuhui Ma; Zhan Xu; Xiao Liu; Weiguo Zou; Jun Wang
Journal:  J Vis Exp       Date:  2018-03-15       Impact factor: 1.355

5.  Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts.

Authors:  Jae-Hyuck Shim; Matthew B Greenblatt; Weiguo Zou; Zhiwei Huang; Marc N Wein; Nicholas Brady; Dorothy Hu; Jean Charron; Heather R Brodkin; Gregory A Petsko; Dennis Zaller; Bo Zhai; Steven Gygi; Laurie H Glimcher; Dallas C Jones
Journal:  J Clin Invest       Date:  2013-08-15       Impact factor: 14.808

Review 6.  The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis.

Authors:  Joachim Sieper; Denis Poddubnyy; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2019-09-24       Impact factor: 20.543

7.  RNA-binding protein SAMD4 regulates skeleton development through translational inhibition of Mig6 expression.

Authors:  Ningning Niu; Jian-Feng Xiang; Qin Yang; Lijun Wang; Zhanying Wei; Ling-Ling Chen; Li Yang; Weiguo Zou
Journal:  Cell Discov       Date:  2017-01-24       Impact factor: 10.849

8.  SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts.

Authors:  Zhan Xu; Matthew B Greenblatt; Guang Yan; Heng Feng; Jun Sun; Sutada Lotinun; Nicholas Brady; Roland Baron; Laurie H Glimcher; Weiguo Zou
Journal:  Nat Commun       Date:  2017-02-20       Impact factor: 14.919

9.  Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer.

Authors:  Guo-Qiang Qin; Hui-Chan He; Zhao-Dong Han; Yu-Xiang Liang; Sheng-Bang Yang; Ya-Qiang Huang; Liang Zhou; Hao Fu; Jie-Xian Li; Fu-Neng Jiang; Wei-de Zhong
Journal:  Onco Targets Ther       Date:  2014-01-24       Impact factor: 4.147

10.  Effects of Interleukin-17A on Osteogenic Differentiation of Isolated Human Mesenchymal Stem Cells.

Authors:  Bilal Osta; Fabien Lavocat; Assia Eljaafari; Pierre Miossec
Journal:  Front Immunol       Date:  2014-09-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.